Mumbai has emerged as a significant hub for pharmaceutical production , with several organizations specializing in the creation of Active Pharmaceutical Ingredients (APIs). Notably, a number of prominent firms are focused on the production of Finasteride API (CAS No: 98319-26-7), meeting the inte